153 related articles for article (PubMed ID: 1279706)
1. Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Srour EF; Tricot G; Hoffman R
Prog Clin Biol Res; 1992; 377():231-7. PubMed ID: 1279706
[No Abstract] [Full Text] [Related]
2. Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation.
Yuan T; Zhou YQ; Herst CV; Reading C; Ellersen D; Etkin M; Khouri I; Kantarjian H; Talpaz M; Deisseroth A
Prog Clin Biol Res; 1992; 377():227-30. PubMed ID: 1438419
[No Abstract] [Full Text] [Related]
3. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
4. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme mediated therapy for chronic myelogenous leukemia.
Leopold LH; Shore SK; Newkirk T; Mangan K; Reddy EP
Prog Clin Biol Res; 1994; 389():175-82. PubMed ID: 7700900
[No Abstract] [Full Text] [Related]
7. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging].
Wu Y; Chen YZ; Huang HF; Chen P; Lu LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661
[TBL] [Abstract][Full Text] [Related]
8. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.
Verfaillie CM; Miller WJ; Boylan K; McGlave PB
Blood; 1992 Feb; 79(4):1003-10. PubMed ID: 1371077
[TBL] [Abstract][Full Text] [Related]
9. Positive stem cell selection--basic science.
Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
[TBL] [Abstract][Full Text] [Related]
10. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
[TBL] [Abstract][Full Text] [Related]
11. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
[TBL] [Abstract][Full Text] [Related]
12. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
13. Use of autotransplants in chronic myeloid leukaemia.
Goldman JM; Deisseroth AB
Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
[TBL] [Abstract][Full Text] [Related]
14. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
Civin CI
Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
[No Abstract] [Full Text] [Related]
15. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
16. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
17. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia.
Maki G; Tam YK; Berkahn L; Klingemann HG
Bone Marrow Transplant; 2003 Jun; 31(12):1119-25. PubMed ID: 12796791
[TBL] [Abstract][Full Text] [Related]
19. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
20. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]